Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-05-29

Modelling pH-Dependence in rational drug design

Obiettivo

Rational drug design relies on accurately and efficiently estimating the binding energies of drug candidates to a protein. There is now experimental evidence that the protonation states (and, hence, the charges) of functional groups in both the protein and ligand can change upon binding, and significantly alter the binding energy. However, this phenomenon is not included in any rational drug design studies.

My goals are to:
(1) extend our current protein pKa prediction methodology (PROPKA) to include the effect of ligand binding on pKa predictions and undertake systematic studies of hundreds of protein-ligand structures to determine
(2) how often it occurs and
(3) how much, on average, it contributes to the binding energy.

The PROPKA method is an empirical pKa predictor developed by the Jensen group, and is among the fastest, most accurate, and easiest to use protein pKa prediction methodology currently available. An on-line version is available (since January 2005) and has been accessed more than 24,000 times. My ultimate goal is to include part of my PROPKA program in docking programs used for rational drug design

Campo scientifico (EuroSciVoc)

Argomento(i)

Invito a presentare proposte

FP6-2004-MOBILITY-12
Vedi altri progetti per questo bando

Meccanismo di finanziamento

EIF - Marie Curie actions-Intra-European Fellowships

Coordinatore

UNIVERSITY OF COPENHAGEN
Contributo UE
Nessun dato
Costo totale
Nessun dato